-les-
glembatumumab
ipilimumab
properdin
presentation
agonistic monoclonal antibody
nacolomab tafenatox
immunoinflammatory
inflammopathology
vapaliximab
atezolizumab
teplizumab
dorlixizumab
immunosorbing
mitumomab
soravtansine
bezlotoxumab
brentuximab
-lim-
secukinumab
C-reactive protein
CRP
antipolyvalent
monospecific
-ner-
toripalimab
sintilimab
pozelimab
ziltivekimab
vanucizumab
alirocumab
nofetumomab
retifanlimab
antiinflammation
monoantibody
dinutuximab
sasanlimab
solitomab
zenocutuzumab
inflammomodulatory
-mab
evolocumab
antiphlogistic
inflammogenic
zanolimumab
pancytokeratin
avdoralimab
fanolesomab
amatuximab
sifalimumab